Fengcai Zhu

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Yanjun Zhang, Gang Zeng, Hongxing Pan et al. · The Lancet Infectious Diseases · 2020 · 1.5K citations · Full text

Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial

Fengcai Zhu, Jun Zhang, Xuefeng Zhang et al. · The Lancet · 2010 · 789 citations

Vaccination, Vaccine Safety, Preventive Medicine +7

Co-infection with respiratory pathogens among COVID-2019 cases

Xiaojuan Zhu, Yiyue Ge, Tao Wu et al. · Virus Research · 2020 · 626 citations · Full text

Respiratory Diseases, Covid-19 Pandemic, Virology +8

Efficacy, Safety, and Immunogenicity of an Enterovirus 71 Vaccine in China

Fengcai Zhu, Wenbo Xu, Jielai Xia et al. · New England Journal of Medicine · 2014 · 458 citations · Full text

Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Fengcai Zhu, Fanyue Meng, Jingxin Li et al. · The Lancet · 2013 · 382 citations

Vaccination, Vaccine Safety, Vaccine Development +5